ArticleIndian journal of thoracic and cardiovascular surgery2025
Urgent mitral valve replacement after mechanical thrombectomy for ischemic stroke.
Article in Indian journal of thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral valve replacement, or any major cardiac surgery, is usually delayed for a minimum of 6 weeks after a previous stroke, mainly to avoid recurrence, if not associated with infective endocarditis or aortic dissection. A 50-year-old lady, diagnosed with severe mitral stenosis with a large left atrial clot, had a sudden onset cerebrovascular accident (CVA) while awaiting surgery. Mechanical thrombectomy (MT) of large vessel M1 middle cerebral artery (MCA) occlusion was done, and after adequate neurological improvement, she was taken up for emergency mitral valve replacement within 12 h, because of hemodynamic instability leading to low cardiac output syndrome and to avoid the chance of future CVA due to large clot burden. A 23-mm mechanical mitral valve prosthesis was implanted, and the postoperative course was uneventful. She was discharged on the fifth postoperative day, with stable hemodynamics and no residual neurological deficit. She was asymptomatic with normal echocardiographic findings on 12 months' follow-up. Major cardiac surgery after MT for ischemic CVA may be a viable option, if indicated, provided post-MT neurological improvement is adequate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.